Theravance Biopharma, Inc.TBPHNASDAQ
LOADING
|||
Switch Symbol:
EV to Sales: Discounted Valuation
Trending lower, below historical average, slight contraction.
Left:
||||
Enterprise value to sales ratio
Latest
7.33
↓ 73% below average
Average (9y)
26.86
Historical baseline
Range
High:103.66
Low:7.33
CAGR
-4.0%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 7.33 | -33.4% |
| 2023 | 10.99 | -2.6% |
| 2022 | 11.29 | -53.6% |
| 2021 | 24.36 | +2.8% |
| 2020 | 23.70 | -8.1% |
| 2019 | 25.77 | +6.8% |
| 2018 | 24.14 | -76.7% |
| 2017 | 103.66 | +286.9% |
| 2016 | 26.79 | +152.5% |
| 2015 | 10.61 | - |